Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CUPRIC ANHYDROUS vs CYCLOBENZAPRINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CUPRIC ANHYDROUS vs CYCLOBENZAPRINE: Safety Overview

Metric CUPRIC ANHYDROUS CYCLOBENZAPRINE
Total FAERS Reports 110 9,148
Deaths Reported 32 3,862
Death Rate 29.1% 42.2%
Hospitalizations 58 2,820
Average Patient Age 57.2 yrs 58.8 yrs
% Female Patients 23.2% 83.2%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Hahnemann Laboratories, INC. REMEDYREPACK INC.
Route ORAL ORAL
Marketing Status N/A Discontinued